A medical director of liver transplants in Colorado says he has noticed a worrying rise in the number of young people in ...

A recent study published in JAMA Psychiatry revealed that Ozempic (semaglutide), a medication commonly used for type 2 ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

Excessive drinking not only impacts young adults' physical health the following day, but also their emotional wellness, new ...

A growing number of young Americans are drinking their way onto the organ transplant list — particularly women.